10.21147/j.issn.1000-9604.2020.03.07
Effectiveness of second-line anti-HER2 treatment in HER2-positive metastatic breast cancer patients previously treated with trastuzumab: A real-world study
32
This work was supported by Capital Clinical Medicine Special Project ;Research number: CSCO-BC RWS 16002
2020-08-28(万方平台首次上网日期,不代表论文的发表时间)
共9页
361-369